Mumps Hoshino and Torii vaccine strains were distinguished from circulating wild strains

Journal of Infection and Chemotherapy

Volumn 19, Issue 3, 2013, Pages 480-485

  Sawada, Akihito ^a   Yamaji, Yoshiaki ^a   Nakayama, Tetsuo ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Molecular differentiation; Mumps Hoshino strain; Mumps Torii strain; Wild circulating genotypes

Indexed keywords

MUMPS VACCINE; RESTRICTION ENDONUCLEASE;

ARTICLE; ASEPTIC MENINGITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; GENETIC ANALYSIS; GENOME SIZE; GENOTYPE; HUMAN; HYDROPHOBICITY; MUMPS HOSHINO VIRUS STRAIN; MUMPS TORII VIRUS STRAIN; MUMPS VIRUS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; ORCHITIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; VIRUS IDENTIFICATION; VIRUS STRAIN; WILD SPECIES;

EID: 84879234046     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0515-3     Document Type: Article

References (24)

1. Kimura M, Kuno-Sakai H, Yamazaki S. Adverse events associated with MMR vaccines in Japan. Acta Paediatr Jpn. 1996;38:205-11.
2. Ueda K, Miyazaki C, Hidaka Y, Okada K, Kusuhara K, Kadoya R. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet. 1995;346:701-2.
3. Nagai T, Okafuji T, Miyazaki C, Ito Y, Kamada M, Kumagai T, et al. A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan. Vaccine. 2007;25:2742-7.
4. Jin L, Rima B, Brown D, Örvell C, Técle T, Afzal M, et al. Proposal for genetic characterization of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch Virol. 2005;150:1903-9.
5. WHO. Mumps virus nomenclature update: 2012. A report based on the WHO mumps nomenclature update meeting, Geneva, 22 September 2011. Wkly Epidemiol Rec. 2012;87:217-24.
6. Sasaki K, Higashihara M, Inoue K, Igarashi Y. Studies on the development of a live attenuated mumps virus vaccine. Kitasato Arch Exp Med. 1976;49:43-52.
7. Hoshino M, Nishimitsu M, Ichimori Y, Oka Y, Kouno R, Yamashita K, et al. Development of live attenuated mumps Torii vaccine strain: development and biological characteristics. Clin Virol. 1981;9:323-30. (in Japanese).
8. Kashiwagi Y, Takami T, Mori T, Nakayama T. Sequence analysis of F, SH, and HN genes among mumps virus strains in Japan. Arch Virol. 1999;144:593-9.
9. Takahashi M, Nakayama T, Kashiwagi Y, Takami T, Sonoda S, Yamanaka T, et al. Single genotype of measles virus is dominant whereas several genotypes of mumps virus are co-circulating. J Med Virol. 1996;62:278-85.
10. Inou Y, Nakayama T, Yoshida N, Uejima H, Yuri K, Kamada M, et al. Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes. J Med Virol. 2004;73:97-104.
11. Otto W, Mankertz A, Santibanez S, Saygilli H, Wenzel J, Jilg E, et al. Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Eur Surveill 2010;15(50):19748
12. Kashiwagi Y, Kawashima H, Takekuma K, Hoshika A, Mori T, Nakayama T. Detection of mumps virus genome directly from clinical samples and a simple method for genetic differentiation of the Hoshino vaccine strain from wild strains of mumps virus. J Med Virol. 1997;52:195-9.
13. Yoshida N, Fujino M, Ota Y, Notomi T, Nakayama T. Simple differentiation of mumps Hoshino vaccine strain from wild strains by reverse transcription loop-mediated isothermal amplification (RT-LAMP). Vaccine. 2007;25:1281-6.
14. CDC. Mumps epidemic - United Kingdom, 2004-2005. MMWR. 2006;55:173-5.
15. CDC. Mumps outbreak at a summer camp: New York, 2005. MMWR. 2006;55:175-7.
16. Barskey AE, Glasser J, LeBaron CW. Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine. 2009;27:6186-95.
17. Rubin SA, Audet SA, Sullivan B, Carbone KM, Bellini WJ, Rota PA, et al. Antibody induced by immunization with Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis. 2008;198:508-15.
18. Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, Rima BK, et al. Mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol. 2012;86:615-20.
19. Atrasheuskaya AV, Blatun EM, Kulak MV, Atrasheuskaya A, Karpov IA, Rubin S. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003. Vaccine. 2007;25:4651-8.
20. Takami T, Kawashima H, Takei Y, Miyajima T, Mori T, Nakayama T, et al. Usefulness of nested PCR and sequence analysis in a nosocomial outbreak of neonatal enterovirus infection. J Clin Virol. 1998;11:67-75.
21. Nakayama T, Onoda K. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994-2004. Vaccine. 2007;25:570-6.
22. Plotkin SA, Rubin SA. Mumps vaccine. In: Plotkin SA, Orenstein W, Offit P, editors. Vaccines. 5th ed. Philadelphia: Saunders Elsevier; 2008. p. 435-65.
23. Yung CF, Andrews N, Bukasa A, Brown KE, Ramsay M. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerg Infect Dis. 2011;17:661-7.
24. Hashimoto H, Fujioka M, Kinumaki H, Kinki Ambulatory Pediatrics Study Group. An office-based prospective study of deafness in mumps. Pediatr Infect Dis J. 2009;28:173-5.